Results

Total Results: 517 records

Showing results for "stage".

1. Evidence Summary: Skin Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/skin-cancer-screening
   April 18, 2023 - inconsistent evidence on the association between clinician skin examination and lesion thickness or stage … Relevance: A substantial nonrandomized evidence base suggests a clear association between earlier stage … Association Between Screening and Stage at Detection Key Question 2. … on stage at melanoma detection. … Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

2. Final Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-kidney-disease-screening
   July 13, 2023 - 5 CKD (end-stage renal disease, including renal replacement) Composite renal outcomes that include … progression to stage 5 CKD and other renal outcomes (e.g., change in estimated GFR or creatinine or … change in albuminuria) KQs 1, 4, 6: Progression to stage 4 or stage 4/5 CKD KQs 2, 5, 8: Any … 4 and 5); however, the treatment population remained focused on earlier-stage CKD (stages 1–3). … and managed in primary care; in addition, CKD stage 4 is uncommon and CKD stage 5 represents end-stage

3. Skin Cancer Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/wKfFrTpC8VtforKLrqGpjQ
   April 18, 2023 - MAIN OUTCOMES AND MEASURES Morbidity; mortality; skin cancer stage, precursor lesions, or lesion thickness … inconsistent evidence on the association between clinician skin examination and lesion thickness or stage … Association Between Screening and Stage at Detection Key Question 2. … stage at melanoma detection. … Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.

4. Draft Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prostate-cancer-screening-adults
   October 12, 2023 - What are the benefits of curative treatment approaches for screen-detected or early-stage prostate cancer … What are the harms of curative treatment approaches for screen-detected or early-stage prostate cancer … literacy) are associated with differences in utilization of treatments for screen-detected or early-stage … prostate cancer (defined as stage I or II) KQs 1-4: Symptomatic men KQs 5, 6: Men with later-stage … prostate cancer (stages III or IV) differ from those for men with early-stage prostate cancer (stages

5. Recommendations in Progress | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/recommendations-in-progress
   June 22, 2025 - Topics Currently in this Stage Developing the Draft Recommendation Statement Systematic … draft recommendation are posted on the USPSTF Web site for public comment Topics Currently in this Stage … and supporting evidence reviews are posted on the Task Force Web site Topics Currently in this Stage … Fractures in Community-Dwelling Adults: Preventive Medication Topics Currently in this Stage … There are no topics at this stage now.

6. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening-adults
   December 21, 2023 - What are the benefits of curative treatment approaches for screen-detected or early-stage prostate cancer … What are the harms of curative treatment approaches for screen-detected or early-stage prostate cancer … prostate cancer (defined as stage I or II) KQs 1–4: Symptomatic men and men with a gene mutation … associated with increased prostate cancer risk KQs 5, 6: Men with later-stage, non-screen–detected … prostate cancer (stages III or IV) differ from those for men with early-stage prostate cancer (stages

7. Final Research Plan: Prostate Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prostate-cancer-screening
   April 28, 2016 - Key question 4 addresses the harms of treatment of early-stage or screen-detected prostate cancer. … Is there evidence that various treatment approaches for early-stage or screen-detected prostate cancer … * Morbidity includes diagnosis of stage IV prostate cancer with attendant symptoms related to pain, … bony metastases, complications due to late-stage disease, and health-related quality of life. … Do the use of various treatment approaches vary by risk factor (e.g., age, race/ethnicity, and stage

8. Final Research Plan: Skin Cancer: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/skin-cancer-screening
   March 25, 2021 - routine skin cancer screening lead to higher rates of detection of precancerous lesions or earlier stage … What is the association between detection of precancerous lesions or earlier stage skin cancer and morbidity … However, outcomes for KQ 2 now are focused on stage or lesion thickness at detection of skin cancer or … 1, 2: No visual skin examination KQ 2: Usual care, (e.g. lesion-directed examination) KQ 4: Stage … USPSTF clarified the wording of KQs 2 and 4 to more clearly delineate precancerous lesions from early-stage

9. Screening for Ovarian Cancer: Review (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/cTa7Hs56-yj4kCr7yXLdRm
   July 01, 1994 - stage II disease. … In the three studies describing the stage at diagnosis, 12 of 13 patients had stage I cancer (11, 12 … Two patients had stage I cancer, two had stage II, and two had stage III at the time of clinical detection … $ Three patients had stage I cancer, one had stage II, six had stage III, and two had stage IV. … Adjuvant therapy in stage I and stage II epithelial ovarian cancer.

10. Draft Research Plan: Chronic Kidney Disease: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/chronic-kidney-disease-screening
    January 19, 2023 - Among adults with CKD stages 1–3, † what are the effects of treatment on likelihood of developing stage … or death) Composite cardiovascular outcomes Quality of life Physical function Progression to stage … 5 CKD (end-stage renal disease, including renal replacement) Composite renal outcomes that include … progression to stage 5 CKD and other renal outcomes (e.g., change in estimated GFR or creatinine or … change in albuminuria) KQs 1, 4, 6: Progression to stage 4 or stage 4/5 CKD KQs 2, 5, 8: Any

11. Archived: Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
    July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … NR Stage IV: 17% vs. 15% vs. … : 31/35     Stage IA: 20/16     Stage IB: 2/1     Stage IIA: 4/4     Stage IIB: 0 … /2     Stage IIIA: 2/4     Stage IIIB: 0/2     Stage IV: 1/0     Unknown: 0/2      … I: 58%   Stage II: 17%   Stage III: 30%   Stage IV: 7%   Additional procedures

12. Archived: Addendum to Screening for Ovarian Cancer: Evidence Update for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement: Ovarian Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
    April 15, 2012 - of ovarian tumors are diagnosed at this stage. … Additionally, the majority (72 percent) of screen-detected cancer cases were late-stage (Stage III or … Overall, 48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify early-stage, slow-growing tumors than later screening cycles.

13. Addendum to Screening for Ovarian Cancer: Evidence Update for the USPSTF Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
    December 31, 2014 - , only 15 percent of ovarian tumors are diagnosed at this stage. … Additionally, the majority (72 percent) of screen-detected cancer cases were late-stage (Stage III … Overall, 48.3 percent of the invasive cancer cases were early stage (Stage I or II), with no significant … stage distribution difference between the two groups. … might be more likely to identify early-stage, slow-growing tumors than later screening cycles.

14. -Umtbplhkqkcqcbeq3Gtuj (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/-UMtbPLHkQKcQCbeQ3gTuJ
    September 01, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early de- … IA: 1.6% (n � 20) vs. 0.3% (n � 4) All stage I: 2.6% (n � 33) vs. 1.0% (n � 12); P � 0.004 Stage II … NR Stage IV: 17% vs. 15% vs. … : 31/35 Stage IA: 20/16 Stage IB: 2/1 Stage IIA: 4/4 Stage IIB: 0/2 Stage IIIA: 2/4 Stage IIIB: 0/2 … I: 58% Stage II: 17% Stage III: 30% Stage IV: 7% Additional procedures Biopsy: NR Surgery: 28 resections

15. Final Research Plan: Lung Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/lung-cancer-screening
    August 16, 2018 - on treatment will be limited to studies of surgical resection or stereotactic body radiotherapy for stage … LDCT) change the incidence of lung cancer and the distribution of lung cancer types and stages (i.e., stage … specified change in lung cancer incidence (and change in distribution of lung cancer stages [i.e., stage … KQs 1–5, 8: Asymptomatic adults (age ≥18 years) KQs 6, 7: Adults (age ≥18 years) with early (stage … shift (where more cancer cases are detected at an earlier stage).

16. Archived: Prostate Cancer: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening-1996
    January 01, 1996 - Survival appears to be longer for persons with early-stage disease 5-year survival is 87% for Stage A … (nonpalpable) tumors, 81% for Stage B (palpable, organ-confined cancer), 64% for Stage C (local extracapsular … is now increasingly diagnosed at a less advanced stage. … Stage C and Stage D disease are often incurable, and the efficacy of treatment for Stage B prostate cancer … Expectant management of early stage prostatic cancer: Swedish experience.

17. Recommendation: Skin Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening
    April 18, 2023 - disease to 31.9% for distant-stage disease. 11 Because keratinocyte carcinoma is common and usually … Results showed that there is a strong, consistent positive association between more advanced stage at … , 31.5 (95% CI, 28.9-34.2) for regional stage, and 169.6 (95% CI, 154.2-186.6) for distant stage. … , 3.9 (95% CI, 3.8-4.1) for regional stage, and 15.8 (95% CI, 14.9-16.7) for distant stage, compared … No evidence was available assessing the association between stage at keratinocyte carcinoma detection

18. Screening for Skin Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zWWcTu328Y27Uu4mPt6ZVF
    August 01, 2022 - and surrounding normal tissue and possibly taking a biopsy of the sentinel lymph node to determine stage … Results showed that there is a strong, consistent positive association between more advanced stage at … , 31.5 (95% CI, 28.9- 34.2) for regional stage, and 169.6 (95% CI, 154.2-186.6) for distant stage. … , 3.9 (95% CI, 3.8-4.1) for regional stage, and 15.8 (95% CI, 14.9-16.7) for distant stage, com- pared … No evidence was available assessing the association between stage at keratinocyte carcinoma detection

19. Procedure Manual Appendix XIII. Template for Scoping the “Decision Problem” to Address Through Decision Modeling | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-xiii-template-scoping-decision-problem-address-through-decision-modeling
    July 01, 2017 - horizon to capture relevant differences across strategies (this may or may not be critical at the scoping stage … determine net impact, such as diagnostic/treatment burden (these may or may not be critical at the scoping stage … intended audience, and original development purpose (these may or may not be critical at the scoping stage

20. Final Research Plan: Breast Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-screening
    May 06, 2021 - subjective well-being Breast cancer mortality All-cause mortality KQ 2: Detection and stage … distribution of screen-detected invasive breast cancer Detection of advanced cancer and stage distribution … standardized and available outcomes will likely vary across studies (e.g., metastatic breast cancer, different stage … possible we will report outcomes for cancers diagnosed at American Joint Committee on Cancer (AJCC) stage